Biotech Analyst Shi, along with Dr. Gartrell, Director of GU Oncology at Montefiore Einstein Cancer Center, will discuss the urothelial cancer treatment landscape with focus on Nectin-4 agents, including PADCEV and clinical candidate BT8009, on an Analyst/Industry conference call to be held on February 10 at 3 pm. Webcast Link
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on BCYC: